Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David W Porter

Showing results (21-30 of 28) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 28 results.
SLAS Discovery : Advancing Life Sciences R & D|July 11, 2017
Identifying Inhibitors of Inflammation: A Novel High-Throughput MALDI-TOF Screening Assay for Salt-Inducible Kinases (SIKs)Rachel E Heap, Anthony G Hope, Lesley-Anne Pearson, et al.
Bioorganic & Medicinal Chemistry Letters|July 1, 2004
Rhodanine-3-acetic acid derivatives as inhibitors of fungal protein mannosyl transferase 1 (PMT1)Michael G Orchard, Judi C Neuss, Carl M S Galley, et al.
Bioorganic & Medicinal Chemistry Letters|December 17, 2013
The discovery of potent, orally bioavailable pyrazolo and triazolopyrimidine CXCR2 receptor antagonistsDavid W Porter, Michelle Bradley, Zarin Brown, et al.
Vaccine|April 20, 2011
A human Phase I/IIa malaria challenge trial of a polyprotein malaria vaccineDavid W Porter, Fiona M Thompson, Tamara K Berthoud, et al.
Bioorganic & Medicinal Chemistry Letters|May 20, 2004
2,3-Dihydro-1,3-dioxo-1H-isoindole-5-carboxylic acid derivatives: a novel class of small molecule heparanase inhibitorsStephen M Courtney, Philip A Hay, Richard T Buck, et al.
Plos One|January 31, 2008
Evidence of blood stage efficacy with a virosomal malaria vaccine in a phase IIa clinical trialFiona M Thompson, David W Porter, Shinji L Okitsu, et al.
The Journal of Infectious Diseases|April 11, 2013
Comparison of modeling methods to determine liver-to-blood inocula and parasite multiplication rates during controlled human malaria infectionAlexander D Douglas, Nick J Edwards, Christopher J A Duncan, et al.
Plos One|July 30, 2011
Impact on malaria parasite multiplication rates in infected volunteers of the protein-in-adjuvant vaccine AMA1-C1/Alhydrogel+CPG 7909Christopher J A Duncan, Susanne H Sheehy, Katie J Ewer, et al.
Pageof 3

Showing results (21-30 of 28) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 28 results.
SLAS Discovery : Advancing Life Sciences R & D|July 11, 2017
Identifying Inhibitors of Inflammation: A Novel High-Throughput MALDI-TOF Screening Assay for Salt-Inducible Kinases (SIKs)Rachel E Heap, Anthony G Hope, Lesley-Anne Pearson, et al.
Bioorganic & Medicinal Chemistry Letters|July 1, 2004
Rhodanine-3-acetic acid derivatives as inhibitors of fungal protein mannosyl transferase 1 (PMT1)Michael G Orchard, Judi C Neuss, Carl M S Galley, et al.
Bioorganic & Medicinal Chemistry Letters|December 17, 2013
The discovery of potent, orally bioavailable pyrazolo and triazolopyrimidine CXCR2 receptor antagonistsDavid W Porter, Michelle Bradley, Zarin Brown, et al.
Vaccine|April 20, 2011
A human Phase I/IIa malaria challenge trial of a polyprotein malaria vaccineDavid W Porter, Fiona M Thompson, Tamara K Berthoud, et al.
Bioorganic & Medicinal Chemistry Letters|May 20, 2004
2,3-Dihydro-1,3-dioxo-1H-isoindole-5-carboxylic acid derivatives: a novel class of small molecule heparanase inhibitorsStephen M Courtney, Philip A Hay, Richard T Buck, et al.
Plos One|January 31, 2008
Evidence of blood stage efficacy with a virosomal malaria vaccine in a phase IIa clinical trialFiona M Thompson, David W Porter, Shinji L Okitsu, et al.
The Journal of Infectious Diseases|April 11, 2013
Comparison of modeling methods to determine liver-to-blood inocula and parasite multiplication rates during controlled human malaria infectionAlexander D Douglas, Nick J Edwards, Christopher J A Duncan, et al.
Plos One|July 30, 2011
Impact on malaria parasite multiplication rates in infected volunteers of the protein-in-adjuvant vaccine AMA1-C1/Alhydrogel+CPG 7909Christopher J A Duncan, Susanne H Sheehy, Katie J Ewer, et al.
Pageof 3